Please login to the form below

Almac group

Almac provides the most comprehensive range of services extending from research through pharmaceutical and clinical development to commercialisation of product. Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 30 years.

This is a FREE listing




Below are full profiles from other companies in this area

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

View profile

Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Learn more about how we are Shortening the distance from lab to life® at syneoshealth.com.

View profile

Company Details

Almac group

Telephone:+44 (0) 28 3833 2200

Address:
Almac House
20 Seagoe Industrial Estate Craigavon
BT63 5QD
United Kingdom

Latest content from PMHub

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today.
Innovative Trials
Live Webinar: Protecting Ownership of Technological & Pharmaceutical Innovation
Fireside Chat with Joshua Goldberg, Co-Managing Partner at Nath, Goldberg & Meyer Impetus Digital
Lucid Group Welcomes a New Cohort of Graduates into its Futures Academy
Lucid Group Communications Limited
Developing Innovative Digital Strategies to Engage Patients
Caitlin Wagner, Associate Marketing Director at Pharming, shares her expertise on innovative patient engagement strategies, including the roles of mobile apps and social media, the impact of the COVID-19 pandemic on how Pharma engages patients, and her predictions for the future. Impetus Digital